Effect of combination therapy of rifampicin and azithromycin on TNF levels during a rat model of chronic osteomyelitis

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 4, 1997, Pages 493-498

  Littlewood Evans, Amanda J ^a   Hattenberger, Marc ^a   Zak, Oto ^a   O'Reilly, T ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; MESSENGER RNA; RIFAMPICIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BONE INFECTION; BONE TURNOVER; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; HISTOPATHOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030951008     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.4.493     Document Type: Article

References (32)

1. Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D. & Mundy, G. R. (1986). Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319, 516-8.
2. 3H]-tetracycline excretion from prelabeled mice. Journal of Bone and Mineral Research 3, 621-7.
3. Saklatvala, J. (1986). Tumour necrosis factor a stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322, 547-9.
4. Thomson, B. M., Mundy, G. R. & Chambers, T. J. (1987). Tumor necrosis factors a and β induce osteoblastic cells to stimulate osteoclastic bone resorption. Journal of Immunology 138, 775-9.
5. Gowen, M., MacDonatd, B. R. & Russell, R. G. (1988). Actions of recombinant human gamma-interleron and tumor necrosis factor alpha on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis and Rheumatism 31, 1500-7.
6. Nair, S. P., Meghji, S., Wilson, M., Reddi, K., White, P. & Henderson, B. (1996). Bacterially induced bone destruction: mechanisms and misconceptions. Infection and Immunity 64, 2371-80.
7. Buchan, G., Barrett, K., Turner, M., Chantry, D., Maini, R. N. & Feldmann, M. (1988). Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clinical and Experimental Immunology 73, 449-55.
8. Chu, C. Q., Field, M., Feldmann, M. & Maini, R. N. (1991). Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis and Rheumatism 34, 1125-32.
9. Pacifici, R., Rifas, L., Teitelbaum, S., Slatopolsky, E., McCracken, R., Bergfeld, M. et al. (1987). Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proceedings of the National Academy of Sciences of the United States of America 84, 4616-20.
10. Klosterhalfen, B., Peters, K. M., Töns, C., Hauptmann, S., Klein, C. L. & Kirkpatrick, C. J. (1996). Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. Journal of Trauma 40, 372-8.
11. Hurley, J. C. (1995). Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Safety 12, 183-95.
12. Henderson, B., & Wilson, M. (1996). Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8, 269-82.
13. Nair, S., Song, Y., Meghji, S., Reddi, K., Harris, M. Ross, A. et al. (1995). Surface-associated proteins from Staphylocccus aureus demonstrate potent bone resorbing activity. Journal of Bone and Mineral Research 10, 726-34.
14. O'Reilly, T., Kunz, S., Sande, E., Zak, O., Sande, M. A. & Tauber, M. G. (1992). Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. Antimicrobial Agents and Chemotherapy 36, 2693-7.
15. Dworkin, R., Modin, G., Kunz, S., Rich, R., Zak, O. & Sande, M. (1990). Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. Antimicrobial Agents and Chemotherapy 34, 1014-6.
16. Norden, C. W. (1988). Lessons learned from animal models of osteomyelitis. Reviews of Infectious Diseases 10, 103-10.
17. Norden, C. W. & Budinsky, A. (1990). Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam. Journal of Infectious Diseases 161, 52-3.
18. Zak, O., Zak, F., Rich, R., Tosch, W., Kradolfer, F. & Scheid, W. M. (1981). Experimental staphylococcal osteomyelitis in rats: therapy with rifampin and cloxacillin, alone or in combination. In Current Chemotherapy and Immunotherapy, Vol. 2. Proceedings of the 12th International Congress of Chemotherapy, Florence, Italy, 1981 (Periti, P. & Grassi, G. G., Eds), pp. 973-4. American Society for Microbiology, Washington, DC.
19. Espevlk, T. & Nissen-Meyer, J. (1986). A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. Journal of Immunological Methods 95, 99-105.
20. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-9.
21. Rooney, P., Bilbe, G., Zak, O. & O'Reilly, T. (1995). Dexamethazone treatment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy. Journal of Medical Microbiology 43, 37-44.
22. Denk, H., Künzle, H., Plenkje, H., Rüschoff, J. & Sellner, W. (1989). Trichromfärbung nach Goldner. In Romeis Mikroskopische Technik, 17th edn (Böck, P., Ed.), p. 558. Urban und Schwarzenberg, Munich.
23. Mohler, J., Fantin, B., Mainardi, J. L. & Carbon, C. (1994). Influence of antimicrobial therapy on kinetics of tumor necrosis factor levels in experimental endocarditis caused by Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 38, 1017-22.
24. Mundy, G. R. (1993). Cytokines and growth factors in the regulation of bone remodeling. Journal of Bone and Mineral Research 8, Suppl. 2, 505-10.
25. Descoteaux, A. & Matlashewski, G. (1990). Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor. Journal of Immunology 145, 846-53.
26. Gordon, J. R. & Galli, S. J. (1990). Mast cells as a source of both preformed and immunologically inducible TNFα/cachectin. Nature 346, 274-6.
27. Gowen, M., Chapman, K., Littlewood, A., Hughes, D., Evans, D. & Russell, G. (1990). Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. Endocrinology 126, 1250-5.
28. Wright, S. C., Jewett, A., Mitsuyasu, R. & Bonavida, B. (1988). Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. Journal of Immunology 141, 99-104.
29. Sosroseno, W. & Herminajeng, E. (1995). The immunopathology of chronic inflammatory periodontal disease. FEMS Immunology and Medical Microbiology 10, 171-80.
30. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussls, D. et al. (1991). Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO Journal 10, 4025-31.
31. Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P. et al. (1993). Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis and Rheumatism 36, 1681-90.
32. Vukicevic, S., Marusic, A., Stavljenic, A., Cesnjaj, M. & Ivankovic, D. (1994). The role of tumor necrosis factor-alpha in the generation of acute phase response and bone loss in rats and talc granulomatosis. Laboratory Investigation 70, 386-91.